BIBLIOGRAPHIE
[1] Passeron A, Dupeux S, Blanchard A. Hyponatrémie : de la
physiopathologie à la pratique. Rev Médecine Interne 2010;31:277–86.
https://doi.org/10.1016/j.revmed.2009.03.369.
[2] Bart’Ter C, Schwartz B. The Syndrome of Inappropriate Secretion
of Antidiuretic Hormone n.d.:17.
[3] Biswas PN, Wilton LV, Pearce GL, Freemantle S, Shakir SAW. The
pharmacovigilance of olanzapine: results of a post-marketing
surveillance study on 8858 patients in England. J Psychopharmacol (Oxf)
2001;15:265–71. https://doi.org/10.1177/026988110101500405.
[4] Mannesse CK, van Puijenbroek EP, Jansen PAF, van Marum RJ,
Souverein PC, Egberts TCG. Hyponatraemia as an Adverse Drug Reaction of
Antipsychotic Drugs: A Case-Control Study in VigiBase. Drug Saf
2010;33:569–78. https://doi.org/10.2165/11532560-000000000-00000.
[5] Wells T, Forsling M. Aminergic control of vasopressin secretion
in the conscious rat. J Physiol Pharmacol 1992;43:57–62.
[6] Yamaguchi K. Inhibitory role of periventricular dopaminergic
mechanisms in hemorrhage-induced vasopressin secretion in conscious rats
n.d.:4.
[7] Rosebraugh CJ, Flockhart DA, Yasuda SU, Woosley RL.
Olanzapine-Induced Rhabdomyolysis. Case Rep n.d.:4.
[8] Karakaya P, Yiş U, Kurul SH, Türkmen MA. Rhabdomyolysis
Associated With Olanzapine Treatment in a Child With Autism: Pediatr
Emerg Care 2010;26:41–2. https://doi.org/10.1097/PEC.0b013e3181c39a22.
[9] Ribeyron S, Guy C, Koenig M, Cathébras P. Rhabdomyolyse et
élévation des enzymes musculaires sous olanzapine. Rev Médecine Interne
2009;30:477–85. https://doi.org/10.1016/j.revmed.2008.12.024.
[10] Meltzer HY. Massive serum creatine kinase increases with
atypical antipsychotic drugs: what is the mechanism and the message?
Psychopharmacology (Berl) 2000;150:349–50.
https://doi.org/10.1007/s002130000465.
[11] Meltzer HY. Skeletal muscle necrosis following membrane-active
drugs plus serotonin. J Neurol Sci 1976;28:41–56.
https://doi.org/10.1016/0022-510X(76)90046-0.